共 50 条
- [21] Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR) [J]. Cardiovascular Drugs and Therapy, 2020, 34 : 889 - 889
- [24] Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry [J]. Scientific Reports, 11
- [26] Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1657 - S1657